Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Genetic Determinants of Clindamycin/Rifampin Interaction

NCT03267225 is registered in ClinicalTrials.gov with Dr Valerie ZELLER as lead sponsor.

NCT NCT03267225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03267225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Genetic Determinants of Clindamycin/Rifampin Interaction
Lead sponsor
Dr Valerie ZELLER
Phase
Observational
Overall status
Completed
Start date
January 31, 2016
Completion date
April 15, 2021
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

va drug interaction